Tradestie Institutional Equity Comparison Engine
ACCL vs TLPH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACCL Overall Edge
ACCL Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ACCL (ACCL) driven by superior Growth & Margin, Momentum & Technical while TLPH counters with relative strength in Valuation, Options & Structure. Fundamentally, ACCL trades at N/M Forward P/E with 4.5% operating margin (+11.3% YoY revenue) versus TLPH at 1.0x Forward P/E and -1474700.0% operating margin (+0.0% YoY). In options structure, ACCL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
TLPH
ACCL N/M vs TLPH 1.0x Fwd P/E
Growth & Margin Winner
ACCL
Op Margin 4.5% vs -1474700.0% ยท YoY +11.3% vs +0.0%
Momentum & Technical Winner
ACCL
1Y -42.4% vs -18.0% ยท 52W Pos 30% vs 20%
Options & Structure Winner
TLPH
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
ACCL
US Equity
ACCL
Institutional Equity
$2.36
-0.84% 1D
Market Cap
$33.5M
1M Return
-12.26%
1Y Return
-42.44%
Forward P/E
N/M
Unified AI Score
63.4 / 100
BUY
Tech 68.0
Fund 58.0
Flow 50.0
Mom 60.0
TLPH
NASDAQ
Talphera, Inc. Common Stock
Pharmaceutical Preparations
$0.86
-4.98% 1D
Market Cap
$53.7M
1M Return
-20.29%
1Y Return
-18.01%
Forward P/E
1.0x
Unified AI Score
37.1 / 100
SELL
Tech 25.0
Fund 45.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ACCL -42.44%
TLPH -18.01%
Spread: +25.66 pp (TLPH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ACCL TTM Op. Margin: 4.5%
TLPH TTM Op. Margin: -1474700.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACCL vs TLPH. Trailing 12-month operating profitability (ACCL 4.5% vs TLPH -1474700.0%) and valuation multiples (ACCL N/M vs TLPH 1.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACCL | TLPH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $33.5M | $53.7M | Larger Scale | TLPH |
| Trailing P/E Ratio Valuation | 120.0x | 1.0x | Lower Multiple | TLPH |
| Forward P/E Ratio Valuation | N/M | 1.0x | Lower Multiple | TLPH |
| Revenue Growth (YoY) Growth | +11.3% | +0.0% | Higher Growth | ACCL |
| Operating Margin (TTM) Profitability | 4.5% | -1474700.0% | Higher Margin | ACCL |
| Net Profit Margin Profitability | 5.5% | 0.0% | Higher Margin | ACCL |
| Return on Equity (ROE) Capital Efficiency | 7.0% | -143.4% | Higher ROE | ACCL |
| 52-Week Range Position Momentum | 30% ($1โ$5) | 20% ($1โ$2) | Stronger Trend | ACCL |
| Beta / 30D Volatility Risk Regime | -0.20ฮฒ ยท 60% Vol | 1.11ฮฒ ยท 58% Vol | Lower Realized Risk | TLPH |
| Unified Institutional Score Composite Signal | 63.4 / 100 (BUY) | 37.1 / 100 (SELL) | Higher Composite | ACCL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ACCL vs TLPH Buy Guide
ACCL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TLPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ACCL nor TLPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.